6-Hydroxykaempferol-3,6,7-triglucosideCAS# 145134-62-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 145134-62-9 | SDF | Download SDF |
PubChem ID | 101634597 | Appearance | Powder |
Formula | C33H40O22 | M.Wt | 788.7 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-hydroxy-2-(4-hydroxyphenyl)-3,6,7-tris[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]chromen-4-one | ||
SMILES | C1=CC(=CC=C1C2=C(C(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)OC6C(C(C(C(O6)CO)O)O)O)O | ||
Standard InChIKey | ZYJKKAOXNQVUMQ-JRMHXNAHSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 6-Hydroxykaempferol 3,6,7-tri-O-glucoside and 6-hydroxykaempferol 3,6-di-O-glucoside can inhibit platelet aggregation induced by collagen, they also show weak inhibitory effects on the adenosine 5'-diphosphate (ADP)- induced platelet aggregation. |
6-Hydroxykaempferol-3,6,7-triglucoside Dilution Calculator
6-Hydroxykaempferol-3,6,7-triglucoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.2679 mL | 6.3395 mL | 12.6791 mL | 25.3582 mL | 31.6977 mL |
5 mM | 0.2536 mL | 1.2679 mL | 2.5358 mL | 5.0716 mL | 6.3395 mL |
10 mM | 0.1268 mL | 0.634 mL | 1.2679 mL | 2.5358 mL | 3.1698 mL |
50 mM | 0.0254 mL | 0.1268 mL | 0.2536 mL | 0.5072 mL | 0.634 mL |
100 mM | 0.0127 mL | 0.0634 mL | 0.1268 mL | 0.2536 mL | 0.317 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 8-Hydroxy-PIPAT oxalate
Catalog No.:BCC6800
CAS No.:1451210-48-2
- Dexmedetomidine HCl
Catalog No.:BCC4347
CAS No.:145108-58-3
- Piribedil dihydrochloride
Catalog No.:BCC6898
CAS No.:1451048-94-4
- Filicenol B
Catalog No.:BCN6446
CAS No.:145103-37-3
- YM 022
Catalog No.:BCC7052
CAS No.:145084-28-2
- Rink Amide Linker
Catalog No.:BCC2833
CAS No.:145069-56-3
- CPI-169
Catalog No.:BCC5396
CAS No.:1450655-76-1
- Candesartan cilexetil
Catalog No.:BCC8900
CAS No.:145040-37-5
- FGIN-1-43
Catalog No.:BCC6739
CAS No.:145040-29-5
- Fmoc-Asp(OMe)-OH
Catalog No.:BCC3090
CAS No.:145038-53-5
- Digalactosyldiacylglycerol
Catalog No.:BCC8941
CAS No.:145033-48-3
- ω-Agatoxin IVA
Catalog No.:BCC7488
CAS No.:145017-83-0
- 6-Hydroxykaempferol 3-Rutinoside -6-glucoside
Catalog No.:BCN1561
CAS No.:145134-63-0
- CP 99994 dihydrochloride
Catalog No.:BCC6016
CAS No.:145148-39-6
- 3beta-Hydroxyporiferast-5-en-7-one
Catalog No.:BCN6256
CAS No.:145163-97-9
- Iodophenpropit dihydrobromide
Catalog No.:BCC6793
CAS No.:145196-87-8
- Kaliotoxin
Catalog No.:BCC7710
CAS No.:145199-73-1
- Rizatriptan Benzoate
Catalog No.:BCC3852
CAS No.:145202-66-0
- Punctanecine
Catalog No.:BCN2018
CAS No.:145204-91-7
- CALP1
Catalog No.:BCC5873
CAS No.:145224-99-3
- Clobenpropit dihydrobromide
Catalog No.:BCC6781
CAS No.:145231-35-2
- Delgrandine
Catalog No.:BCN8122
CAS No.:145237-05-4
- Sahandol
Catalog No.:BCN6996
CAS No.:1452398-07-0
- Diarylcomosol III
Catalog No.:BCN7201
CAS No.:1452487-93-2
Antiplatelet Aggregatory Effects of the Constituents Isolated from the Flower of Cartham.ua tinctorius
Natural Med., 2005, 59(5):241-4.
Four constituents, 6-Hydroxykaempferol 3,6,7-trrO-glucoside ( 1 ) , 6-hydroxykaempferol 3-Orutinoside-6-0-glucoside (2), 6'hydroxykaempferol 3,6-dr0-glueoside (3), and syringin (4) were isolated from the flower of Carthamus tinctorius L. and were examined for the inhibitory effects on platelet aggregation. The platelet aggregation was monitored by a platelet aggregometer employing a laser-scattering method. The compounds were identified on the basis of NMR spectral data. Compound 1, 3 and 4 inhibited platelet aggregation induced by collagen. Compound 4 also showed an antiplatelet aggregatory effect when the platelet aggregation was induced by adenosine 5'-diphosphate (ADP). However, 2 showed no inhibitory effect on platelet aggregation induced by collagen or ADP. Furthermore, 1 and 3 showed weak inhibitory effects on the ADP-induced platelet aggregation.